Heron Therapeutics, Inc. (HRTX)
USD 2.31
(-1.7%)
USD 2.31
(-1.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 179.62 Million USD | 14.07% |
| 2022 | 157.47 Million USD | -1.27% |
| 2021 | 159.49 Million USD | 548.06% |
| 2020 | 24.61 Million USD | 24.35% |
| 2019 | 19.79 Million USD | 332.71% |
| 2018 | 4.57 Million USD | -84.05% |
| 2017 | 28.68 Million USD | -45.79% |
| 2016 | 52.91 Million USD | 2281.23% |
| 2015 | 2.22 Million USD | 39.05% |
| 2014 | 1.59 Million USD | 55.9% |
| 2013 | 1.02 Million USD | 108.33% |
| 2012 | 492 Thousand USD | 377.67% |
| 2011 | 103 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | -100.0% |
| 1999 | 3.3 Million USD | 6.45% |
| 1998 | 3.1 Million USD | -44.64% |
| 1997 | 5.6 Million USD | -12.5% |
| 1996 | 6.4 Million USD | -12.33% |
| 1995 | 7.3 Million USD | 128.13% |
| 1994 | 3.2 Million USD | -13.51% |
| 1993 | 3.7 Million USD | -7.5% |
| 1992 | 4 Million USD | 0.0% |
| 1991 | 4 Million USD | 33.33% |
| 1990 | 3 Million USD | 0.0% |
| 1989 | 3 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 179.17 Million USD | -0.25% |
| 2024 Q2 | 178.71 Million USD | -0.26% |
| 2023 Q3 | 179.99 Million USD | 15.29% |
| 2023 Q1 | 156.92 Million USD | -0.35% |
| 2023 Q2 | 156.12 Million USD | -0.51% |
| 2023 FY | 179.62 Million USD | 14.07% |
| 2023 Q4 | 179.62 Million USD | -0.21% |
| 2022 Q3 | 158 Million USD | -0.32% |
| 2022 Q4 | 157.47 Million USD | -0.33% |
| 2022 Q2 | 158.51 Million USD | -0.31% |
| 2022 FY | 157.47 Million USD | -1.27% |
| 2022 Q1 | 159 Million USD | -0.31% |
| 2021 FY | 159.49 Million USD | 548.06% |
| 2021 Q3 | 164.5 Million USD | -0.4% |
| 2021 Q2 | 165.15 Million USD | 576.15% |
| 2021 Q1 | 24.42 Million USD | -0.75% |
| 2021 Q4 | 159.49 Million USD | -3.04% |
| 2020 Q1 | 25.39 Million USD | 28.32% |
| 2020 Q3 | 24.84 Million USD | -1.05% |
| 2020 Q4 | 24.61 Million USD | -0.95% |
| 2020 FY | 24.61 Million USD | 24.35% |
| 2020 Q2 | 25.11 Million USD | -1.13% |
| 2019 Q4 | 19.79 Million USD | 10.83% |
| 2019 FY | 19.79 Million USD | 332.71% |
| 2019 Q3 | 17.85 Million USD | -1.09% |
| 2019 Q2 | 18.05 Million USD | -2.81% |
| 2019 Q1 | 18.57 Million USD | 306.12% |
| 2018 Q2 | 29.11 Million USD | 0.75% |
| 2018 FY | 4.57 Million USD | -84.05% |
| 2018 Q4 | 4.57 Million USD | 5.44% |
| 2018 Q3 | 4.33 Million USD | -85.1% |
| 2018 Q1 | 28.89 Million USD | 0.73% |
| 2017 Q4 | 28.68 Million USD | 0.71% |
| 2017 FY | 28.68 Million USD | -45.79% |
| 2017 Q1 | 53.09 Million USD | 0.35% |
| 2017 Q2 | 28.28 Million USD | -46.73% |
| 2017 Q3 | 28.48 Million USD | 0.69% |
| 2016 Q3 | 52.73 Million USD | 1961.45% |
| 2016 Q2 | 2.55 Million USD | 7.12% |
| 2016 FY | 52.91 Million USD | 2281.23% |
| 2016 Q1 | 2.38 Million USD | 7.47% |
| 2016 Q4 | 52.91 Million USD | 0.34% |
| 2015 Q2 | 1.9 Million USD | 8.81% |
| 2015 Q1 | 1.74 Million USD | 9.45% |
| 2015 Q3 | 2.06 Million USD | 8.3% |
| 2015 Q4 | 2.22 Million USD | 7.81% |
| 2015 FY | 2.22 Million USD | 39.05% |
| 2014 FY | 1.59 Million USD | 55.9% |
| 2014 Q1 | 1.16 Million USD | 13.56% |
| 2014 Q4 | 1.59 Million USD | 10.21% |
| 2014 Q3 | 1.45 Million USD | 11.03% |
| 2014 Q2 | 1.3 Million USD | 12.2% |
| 2013 Q2 | 754 Thousand USD | 21.22% |
| 2013 Q3 | 888 Thousand USD | 17.77% |
| 2013 Q4 | 1.02 Million USD | 15.43% |
| 2013 FY | 1.02 Million USD | 108.33% |
| 2013 Q1 | 622 Thousand USD | 26.42% |
| 2012 FY | 492 Thousand USD | 377.67% |
| 2012 Q1 | 100 Thousand USD | -2.91% |
| 2012 Q3 | 400 Thousand USD | 67.36% |
| 2012 Q2 | 239 Thousand USD | 139.0% |
| 2012 Q4 | 492 Thousand USD | 23.0% |
| 2011 Q4 | 103 Thousand USD | 60.94% |
| 2011 FY | 103 Thousand USD | 0.0% |
| 2011 Q3 | 64 Thousand USD | 156.0% |
| 2011 Q2 | 25 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2000 Q3 | - USD | -100.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | 2.86 Million USD | -7.08% |
| 2000 Q1 | 3.08 Million USD | -6.4% |
| 2000 FY | - USD | -100.0% |
| 1999 Q1 | 4.3 Million USD | 38.71% |
| 1999 Q2 | 3.8 Million USD | -11.63% |
| 1999 Q3 | 3.9 Million USD | 2.63% |
| 1999 Q4 | 3.3 Million USD | -15.38% |
| 1999 FY | 3.3 Million USD | 6.45% |
| 1998 Q4 | 3.1 Million USD | -16.22% |
| 1998 Q1 | 5 Million USD | -10.71% |
| 1998 FY | 3.1 Million USD | -44.64% |
| 1998 Q2 | 4.3 Million USD | -14.0% |
| 1998 Q3 | 3.7 Million USD | -13.95% |
| 1997 Q3 | 6.2 Million USD | -4.62% |
| 1997 Q1 | 6.8 Million USD | 6.25% |
| 1997 FY | 5.6 Million USD | -12.5% |
| 1997 Q2 | 6.5 Million USD | -4.41% |
| 1997 Q4 | 5.6 Million USD | -9.68% |
| 1996 FY | 6.4 Million USD | -12.33% |
| 1996 Q4 | 6.4 Million USD | -28.09% |
| 1996 Q1 | 7.7 Million USD | 5.48% |
| 1996 Q3 | 8.9 Million USD | 8.54% |
| 1996 Q2 | 8.2 Million USD | 6.49% |
| 1995 Q3 | 6.1 Million USD | 110.34% |
| 1995 Q4 | 7.3 Million USD | 19.67% |
| 1995 FY | 7.3 Million USD | 128.13% |
| 1995 Q1 | 3.1 Million USD | -3.13% |
| 1995 Q2 | 2.9 Million USD | -6.45% |
| 1994 Q2 | 3.4 Million USD | -5.56% |
| 1994 Q1 | 3.6 Million USD | -2.7% |
| 1994 Q4 | 3.2 Million USD | -5.88% |
| 1994 FY | 3.2 Million USD | -13.51% |
| 1994 Q3 | 3.4 Million USD | 0.0% |
| 1993 Q1 | 3.9 Million USD | -2.5% |
| 1993 FY | 3.7 Million USD | -7.5% |
| 1993 Q2 | 3.9 Million USD | 0.0% |
| 1993 Q3 | 3.8 Million USD | -2.56% |
| 1993 Q4 | 3.7 Million USD | -2.63% |
| 1992 Q4 | 4 Million USD | 0.0% |
| 1992 Q2 | 4 Million USD | 0.0% |
| 1992 Q1 | 4 Million USD | 0.0% |
| 1992 FY | 4 Million USD | 0.0% |
| 1992 Q3 | 4 Million USD | 0.0% |
| 1991 Q2 | 3 Million USD | 0.0% |
| 1991 FY | 4 Million USD | 33.33% |
| 1991 Q3 | 3 Million USD | 0.0% |
| 1991 Q4 | 4 Million USD | 33.33% |
| 1991 Q1 | 3 Million USD | 0.0% |
| 1990 Q2 | 3 Million USD | 0.0% |
| 1990 Q4 | 3 Million USD | 0.0% |
| 1990 Q3 | 3 Million USD | 0.0% |
| 1990 FY | 3 Million USD | 0.0% |
| 1990 Q1 | 3 Million USD | 0.0% |
| 1989 FY | 3 Million USD | 0.0% |
| 1989 Q4 | 3 Million USD | 0.0% |
| 1989 Q2 | 3 Million USD | 0.0% |
| 1989 Q3 | 3 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -126398.592% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2245.81% |
| XOMA Corporation | 124.45 Million USD | -44.337% |
| Mesoblast Limited | 118.92 Million USD | -51.046% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 21.625% |
| Aptorum Group Limited | 3.36 Million USD | -5242.26% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -13725.877% |
| HilleVax, Inc. | 51.19 Million USD | -250.884% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -617.307% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -760.113% |
| Precision BioSciences, Inc. | 31.26 Million USD | -474.479% |
| Dyadic International, Inc. | 136.92 Thousand USD | -131083.314% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -113588.608% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -6154.457% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3192.906% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -83838.318% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3184.476% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 21.708% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1345.815% |
| IGM Biosciences, Inc. | 40.5 Million USD | -343.46% |
| Opthea Limited | 200.62 Million USD | 10.467% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -246.94% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3226.444% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1730.511% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -2813.674% |
| NextCure, Inc. | 6.6 Million USD | -2619.576% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -28778.96% |
| Ovid Therapeutics Inc. | 46 Million USD | -290.481% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -745.746% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -494.48% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -189.373% |
| Senti Biosciences, Inc. | 37.66 Million USD | -376.897% |
| Apollomics, Inc. | 4.66 Million USD | -3753.851% |
| PureTech Health plc | 25.51 Million USD | -604.092% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -56386.792% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1284.31% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -112.141% |
| ChromaDex Corporation | 3.27 Million USD | -5381.477% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -72.418% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -371.415% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -71.442% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -73.493% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -77.176% |
| Fortress Biotech, Inc. | 88.59 Million USD | -102.759% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -184.37% |
| Celcuity Inc. | 37.44 Million USD | -379.695% |
| ContextLogic Inc. | 6 Million USD | -2893.8% |
| GH Research PLC | 343 Thousand USD | -52269.679% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -2638.649% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -485381.081% |
| ImmuCell Corporation | 11.96 Million USD | -1400.739% |
| Amarin Corporation plc | 8.73 Million USD | -1955.946% |
| TG Therapeutics, Inc. | 110.79 Million USD | -62.126% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -208.21% |
| Acelyrin, Inc. | 1.19 Million USD | -14944.221% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -535.649% |
| Novavax, Inc. | 280.63 Million USD | 35.992% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -29.201% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.901% |
| AnaptysBio, Inc. | 17.81 Million USD | -908.353% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3228.293% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1252.01% |
| AbCellera Biologics Inc. | 77.38 Million USD | -132.138% |
| CorMedix Inc. | 667.63 Thousand USD | -26805.241% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1539.69% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 93.354% |
| Aptose Biosciences Inc. | 1 Million USD | -17688.367% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2075084.843% |
| Soligenix, Inc. | 3.49 Million USD | -5040.216% |
| Century Therapeutics, Inc. | 48.17 Million USD | -272.897% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -55.966% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -39766.747% |
| Kura Oncology, Inc. | 17.2 Million USD | -944.349% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2501.043% |
| Ardelyx, Inc. | 55.98 Million USD | -220.867% |
| Ainos, Inc. | 5.96 Million USD | -2912.095% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -94.333% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -8254.791% |
| Prothena Corporation plc | 11.83 Million USD | -1417.769% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1185.444% |
| Autolus Therapeutics plc | 52.96 Million USD | -239.132% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -611.821% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -329.29% |
| Celularity Inc. | 65.41 Million USD | -174.589% |
| Rallybio Corporation | 392 Thousand USD | -45723.469% |
| GRI Bio, Inc. | 14 Thousand USD | -1282957.143% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 46.9% |
| INmune Bio, Inc. | 10.43 Million USD | -1621.069% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2940.904% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -219816.748% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -21624.533% |
| Humacyte, Inc. | 58.1 Million USD | -209.138% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -210.388% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 62.643% |
| Immunocore Holdings plc | 84.03 Million USD | -113.761% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -9593.902% |
| Verastem, Inc. | 41.55 Million USD | -332.245% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1479.564% |
| Histogen Inc. | 4.62 Million USD | -3786.37% |
| Surrozen, Inc. | 3.37 Million USD | -5216.011% |
| Blueprint Medicines Corporation | 774.12 Million USD | 76.796% |
| Organovo Holdings, Inc. | 1.39 Million USD | -12785.796% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -7102.406% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -309603.448% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -112.356% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -85838.188% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -3479.673% |
| Summit Therapeutics Inc. | 106.09 Million USD | -69.302% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -62.768% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -110564.933% |
| Turnstone Biologics Corp. | 3.21 Million USD | -5488.923% |
| Pulmatrix, Inc. | 8.75 Million USD | -1951.485% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -72623.887% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -84.032% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1196.953% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -55.73% |
| Cytokinetics, Incorporated | 755.77 Million USD | 76.232% |
| Exelixis, Inc. | 189.94 Million USD | 5.431% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -486.751% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -61.932% |
| Evogene Ltd. | 1.13 Million USD | -15684.534% |
| Replimune Group, Inc. | 75.86 Million USD | -136.761% |
| PDS Biotechnology Corporation | 23.85 Million USD | -653.106% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -325519.505% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6347.523% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -223518.166% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -367462.922% |
| BioLineRx Ltd. | 11.59 Million USD | -1449.72% |
| Avid Bioservices, Inc. | 207.83 Million USD | 13.571% |
| Insmed Incorporated | 1.2 Billion USD | 85.081% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -8373.019% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -292.432% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -276250.769% |
| MediWound Ltd. | 6.71 Million USD | -2576.62% |
| MiMedx Group, Inc. | 48.09 Million USD | -273.455% |
| OmniAb, Inc. | 25.56 Million USD | -602.742% |
| Alector, Inc. | 38.91 Million USD | -361.555% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 16.037% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 56.719% |
| Mereo BioPharma Group plc | 5.95 Million USD | -2917.944% |
| Zai Lab Limited | 15.15 Million USD | -1085.585% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 62.455% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -10886.422% |
| Aura Biosciences, Inc. | 19.55 Million USD | -818.484% |
| Immunic, Inc. | 1.33 Million USD | -13365.367% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -555.218% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -466.078% |
| Veracyte, Inc. | 12.63 Million USD | -1322.233% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 72.145% |
| FibroGen, Inc. | 170.45 Million USD | -5.381% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1878.064% |
| Allakos Inc. | 41.46 Million USD | -333.204% |
| scPharmaceuticals Inc. | 40.26 Million USD | -346.07% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1559.994% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -118858.94% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -10894.855% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -87991.373% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -4139.509% |
| Precigen, Inc. | 7.09 Million USD | -2431.041% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 89.295% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2354.941% |
| Incyte Corporation | 38.28 Million USD | -369.162% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -59633.833% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -316.123% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1512.749% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6347.523% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 24.726% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -589.736% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -51369.341% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -568.234% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -298.527% |
| Agenus Inc. | 350.24 Million USD | 48.714% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -167947.824% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -12558.774% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -297.091% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -316.104% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -272.448% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -109451.312% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 78.835% |
| UroGen Pharma Ltd. | 100.21 Million USD | -79.244% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -17383.779% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 1.708% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1265420.643% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -58794.426% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -45723.236% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -2528.061% |
| Chimerix, Inc. | 2.14 Million USD | -8278.172% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -18361.254% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -405.208% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -103927.845% |
| Pluri Inc. | 29.61 Million USD | -506.605% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1122.375% |
| MeiraGTx Holdings plc | 89.26 Million USD | -101.232% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -841248.946% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -3583.166% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -190.576% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -72.56% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2496.906% |
| NLS Pharmaceutics AG | 1.63 Million USD | -10894.855% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -469.38% |
| Nutriband Inc. | 241.28 Thousand USD | -74346.402% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3185.678% |
| Vor Biopharma Inc. | 35.66 Million USD | -403.724% |
| Roivant Sciences Ltd. | 499.74 Million USD | 64.056% |
| ProKidney Corp. | 4.41 Million USD | -3970.428% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -14551.55% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3277.644% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 89.676% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -31692.566% |
| Bicycle Therapeutics plc | 44.95 Million USD | -299.564% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -361.531% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -150.154% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -104.253% |
| Atai Life Sciences N.V. | 16.47 Million USD | -990.24% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -7228.776% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -26511.556% |
| MediciNova, Inc. | 215.92 Thousand USD | -83089.611% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -7099.519% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -14144.569% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -15643.032% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 3.619% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1644.639% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -221.574% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -4903.565% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1860.79% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1124.375% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1365.394% |
| bluebird bio, Inc. | 330.32 Million USD | 45.621% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1336.335% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -10955.977% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 84.158% |
| BioAtla, Inc. | 2.46 Million USD | -7201.951% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -88.842% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3138.875% |
| DBV Technologies S.A. | 14.38 Million USD | -1149.065% |
| Fortress Biotech, Inc. | 88.59 Million USD | -102.759% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1723.264% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -848.756% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1089.983% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -753.421% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -54917.412% |
| Galecto, Inc. | 249 Thousand USD | -72039.759% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -10908.473% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 88.019% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -69.358% |
| Entera Bio Ltd. | 390 Thousand USD | -45958.462% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 55.624% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -2793.492% |
| Xencor, Inc. | 83.43 Million USD | -115.294% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -10547.777% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -3797.331% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -14572.781% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1810.123% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -109451.312% |
| Portage Biotech Inc. | 47 Thousand USD | -382087.234% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -14144.569% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -7331.858% |
| OncoCyte Corporation | 2.86 Million USD | -6160.997% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -119211.343% |
| Purple Biotech Ltd. | 351 Thousand USD | -51076.068% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -5586.23% |
| Onconetix, Inc. | 9.88 Million USD | -1717.036% |
| MacroGenics, Inc. | 33.97 Million USD | -428.769% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -8731.273% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3333.913% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -1217.597% |
| Aditxt, Inc. | 18.21 Million USD | -885.993% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -571.808% |
| Curis, Inc. | 2.79 Million USD | -6329.062% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -8307.783% |
| Adagene Inc. | 22.3 Million USD | -705.259% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -973.624% |
| BeiGene, Ltd. | 930.18 Million USD | 80.689% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 14.52% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -22120.133% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 70.599% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -236252.632% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -7079.376% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -119.014% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 12.766% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -3767.959% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 93.304% |
| ADMA Biologics, Inc. | 141.41 Million USD | -27.019% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -196.519% |
| Clene Inc. | 32.16 Million USD | -458.527% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -6966.404% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -852.782% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -8083.508% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -254.492% |
| Adicet Bio, Inc. | 20.92 Million USD | -758.478% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 7.021% |
| Absci Corporation | 15.95 Million USD | -1025.7% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1073.809% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -785.172% |
| Surrozen, Inc. | 3.37 Million USD | -5216.011% |
| Generation Bio Co. | 97.89 Million USD | -83.492% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -54498.176% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -553.549% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -610.048% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -631.921% |
| Invivyd, Inc. | 2.16 Million USD | -8196.905% |
| Cingulate Inc. | 3.13 Million USD | -5629.58% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -235.967% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -5097566.393% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -35760.835% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3140.628% |
| Jaguar Health, Inc. | 35.86 Million USD | -400.915% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -285023.81% |
| 2seventy bio, Inc. | 256.67 Million USD | 30.017% |
| Clearside Biomedical, Inc. | 43 Million USD | -317.73% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -29689.055% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -214.008% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3100.696% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -37225.687% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -535.357% |
| Innoviva, Inc. | 449.07 Million USD | 60.001% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -788.412% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -163.268% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -944.531% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -44.233% |
| Evaxion Biotech A/S | 10.86 Million USD | -1552.56% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -115.41% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -139.801% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -2665.209% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -438017.073% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -565.535% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -38529.677% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -554.884% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1658.817% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -4949.986% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -11451.64% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -14156.19% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1143.617% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -19726.49% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -247.255% |
| ImmunityBio, Inc. | 883.67 Million USD | 79.673% |
| Korro Bio, Inc. | 33.2 Million USD | -440.934% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -153.083% |
| Kineta, Inc. | 1.31 Million USD | -13539.18% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -76509.901% |
| BioVie Inc. | 6.11 Million USD | -2839.206% |
| Codexis, Inc. | 22.36 Million USD | -703.202% |
| Celularity Inc. | 65.41 Million USD | -174.589% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -46800.261% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -79983.816% |
| Kodiak Sciences Inc. | 181.63 Million USD | 1.103% |
| Cibus, Inc. | 24.62 Million USD | -629.572% |
| Annexon, Inc. | 31.35 Million USD | -472.885% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -7569.855% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 87.642% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -139.389% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -4502.306% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -1015.164% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -61.116% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -290.165% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -459.275% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -18136.345% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1467.845% |
| Alkermes plc | 290.73 Million USD | 38.215% |
| Arcellx, Inc. | 97.62 Million USD | -83.998% |
| Moolec Science SA | 2.64 Million USD | -6690.487% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -8258.678% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -2745.367% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -577.509% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -5690.716% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -7378.268% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -10265.147% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -209.138% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -530.561% |
| Geron Corporation | 85.89 Million USD | -109.115% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -294.7% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 97.072% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -155754.027% |
| Notable Labs, Ltd. | 2.04 Million USD | -8666.618% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -430.973% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3194.113% |
| IN8bio, Inc. | 4.89 Million USD | -3571.122% |
| 89bio, Inc. | 27.1 Million USD | -562.638% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -44807.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -234.453% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -7030.925% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -13325.112% |
| Liquidia Corporation | 3.5 Million USD | -5027.833% |
| Mustang Bio, Inc. | 2.49 Million USD | -7090.873% |
| Immunovant, Inc. | 138 Thousand USD | -130065.217% |
| Vericel Corporation | 88.14 Million USD | -103.792% |
| Quantum-Si incorporated | 15.3 Million USD | -1073.809% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1959.718% |
| XOMA Corporation | 124.45 Million USD | -44.337% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -65457.664% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -219816.748% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1253.028% |
| Vaxcyte, Inc. | 29.22 Million USD | -514.659% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1547.51% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -88386.7% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -769.406% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -10766.788% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -14156.19% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -44472.705% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -17305.814% |
| PepGen Inc. | 20.1 Million USD | -793.494% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -31194.077% |
| United Therapeutics Corporation | 700 Million USD | 74.339% |
| Solid Biosciences Inc. | 26.26 Million USD | -583.906% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -18136.345% |
| Immuneering Corporation | 4.46 Million USD | -3924.863% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -177749.505% |
| Belite Bio, Inc | 886 Thousand USD | -20174.041% |
| Pharming Group N.V. | 171.54 Million USD | -4.712% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 25.036% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -742.098% |
| uniQure N.V. | 138.4 Million USD | -29.781% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -967.308% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -110.281% |
| Altimmune, Inc. | 671 Thousand USD | -26670.194% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1253.028% |
| Peak Bio, Inc. | 10.72 Million USD | -1575.352% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1878.064% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -10182.084% |
| Benitec Biopharma Inc. | 284 Thousand USD | -63149.296% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 59.64% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -61917.035% |
| Compugen Ltd. | 1.35 Million USD | -13195.929% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -85238.426% |
| argenx SE | 20 Million USD | -798.14% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -320.025% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -112.439% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -801.702% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -53.275% |
| PolyPid Ltd. | 11.77 Million USD | -1424.985% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -96.405% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -4196.293% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -30605.641% |
| Instil Bio, Inc. | 86.05 Million USD | -108.739% |
| Elevation Oncology, Inc. | 30.13 Million USD | -496.038% |
| Immunome, Inc. | 1.65 Million USD | -10786.545% |
| Verona Pharma plc | 51.32 Million USD | -249.954% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1737.063% |
| Shattuck Labs, Inc. | 4.2 Million USD | -4174.822% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -49520.994% |
| Design Therapeutics, Inc. | 3.05 Million USD | -5789.443% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -68460.305% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1162.496% |
| Achilles Therapeutics plc | 4.61 Million USD | -3792.264% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 51.935% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -496.791% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -4757.612% |
| Beam Therapeutics Inc. | 173.17 Million USD | -3.727% |
| Moolec Science SA | 2.64 Million USD | -6690.487% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -37716.421% |
| AEON Biopharma, Inc. | 278 Thousand USD | -64514.388% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2457.346% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -53520.299% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -136.783% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -193.957% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -494.613% |
| Athira Pharma, Inc. | 1.58 Million USD | -11232.997% |
| HCW Biologics Inc. | 6.45 Million USD | -2684.163% |
| XOMA Corporation | 124.45 Million USD | -44.337% |
| NeurAxis, Inc. | 224.26 Thousand USD | -79998.1% |
| Lumos Pharma, Inc. | 6.58 Million USD | -2627.836% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1737.063% |
| 180 Life Sciences Corp. | 1.32 Million USD | -13507.471% |
| Nektar Therapeutics | 230.4 Million USD | 22.037% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -801.702% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -951.679% |
| Arvinas, Inc. | 3.4 Million USD | -5183.176% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -11451.64% |
| Palisade Bio, Inc. | 369 Thousand USD | -48579.675% |
| Nutriband Inc. | 241.28 Thousand USD | -74346.402% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -10908.473% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -21646.731% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -43183.855% |
| Merus N.V. | 12.16 Million USD | -1376.961% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -39.867% |
| Neurogene Inc. | 16.25 Million USD | -1005.063% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 41.706% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -529.368% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1200.333% |
| Rezolute, Inc. | 2.22 Million USD | -7962.298% |
| Clene Inc. | 32.16 Million USD | -458.527% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -102513.494% |
| BeyondSpring Inc. | 3.99 Million USD | -4396.32% |
| Synlogic, Inc. | 17.27 Million USD | -939.815% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -13717.538% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -513122.857% |
| Peak Bio, Inc. | 10.72 Million USD | -1575.352% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -245.951% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2119.274% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -1.476% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2445.388% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -131405.044% |
| MannKind Corporation | 382.37 Million USD | 53.024% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1572.825% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -43818.826% |
| Gossamer Bio, Inc. | 212.46 Million USD | 15.455% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -103134.483% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1860.79% |
| Legend Biotech Corporation | 328.67 Million USD | 45.347% |
| Mural Oncology plc | 15 Million USD | -1096.802% |
| Disc Medicine, Inc. | 2.1 Million USD | -8449.643% |
| Champions Oncology, Inc. | 7.43 Million USD | -2317.604% |
| REGENXBIO Inc. | 89.29 Million USD | -101.174% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -20916.571% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -32383.517% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3217.843% |
| Vaxart, Inc. | 26.51 Million USD | -577.484% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1047.243% |
| Cellectis S.A. | 92.85 Million USD | -93.454% |
| Longeveron Inc. | 2.04 Million USD | -8700.98% |
| Repare Therapeutics Inc. | 3.41 Million USD | -5167.683% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 87.14% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -285.534% |
| Revolution Medicines, Inc. | 87.94 Million USD | -104.253% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -103731.214% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -4444.093% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -56564.984% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -102544.571% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 77.78% |
| Denali Therapeutics Inc. | 52.24 Million USD | -243.845% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1146.944% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -12973.362% |
| Cingulate Inc. | 3.13 Million USD | -5629.58% |
| Passage Bio, Inc. | 26.29 Million USD | -583.152% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -2595.094% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -43926.471% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -19992.617% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -773.635% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -7228.402% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -5651.777% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -22048.952% |
| OmniAb, Inc. | 25.56 Million USD | -602.742% |
| Anew Medical, Inc. | 1.6 Million USD | -11091.776% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -507.203% |
| Lipocine Inc. | 17.16 Thousand USD | -1046317.337% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1443.461% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -418.736% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2940.904% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -214.183% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -88386.7% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -3377.793% |
| Ocugen, Inc. | 6.94 Million USD | -2487.927% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1171.343% |
| Q32 Bio Inc. | 1.31 Million USD | -13528.832% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -26630.357% |
| Alumis Inc. Common Stock | 32.58 Million USD | -451.344% |
| Equillium, Inc. | 824 Thousand USD | -21699.515% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1878.5% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -59615.564% |
| Dominari Holdings Inc. | 3.02 Million USD | -5832.232% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -190008.692% |
| vTv Therapeutics Inc. | 529 Thousand USD | -33856.144% |
| Bio-Techne Corporation | 419.53 Million USD | 57.184% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -149.497% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 7.201% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -963.643% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -689.157% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -2865.137% |
| Nkarta, Inc. | 88.33 Million USD | -103.339% |
| BioCardia, Inc. | 1.31 Million USD | -13559.924% |
| Iterum Therapeutics plc | 19.5 Million USD | -820.744% |